Archive - April 2019
Meaningful Analytics Data for Quick Decision Making in Development of Viral Vector-Based Therapies
Kyowa Kirin Announces FDA Acceptance of Istradefylline (KW-6002) New Drug Application Resubmission in the US
Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Biologics License Application to U.S. FDA
FDA Approves Evenity (romosozumab-aqqg) for the Treatment of Osteoporosis in Postmenopausal Women at High Risk of Fracture
Dovato approval key for Glaxo in HIV treatment
FDA refuses Zogenix’s seizure drug Fintepla
Nanna Theraputics awarded Innovate UK grant as it appoints new board member
Another EU patent for Verona in COPD drug